Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-08-12
1999-03-09
Wu, Shean C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514212, 514217, 540522, 540523, 540524, A61K 3155, A01N 4346, C07D49804
Patent
active
058801197
ABSTRACT:
The present invention relates to certain novel mercaptoacetylamido inhibitors of enkephalinase and of ACE.
REFERENCES:
patent: 3334091 (1967-08-01), Houlihan
patent: 3334095 (1967-08-01), Houlihan
patent: 4080449 (1978-03-01), Croisier et al.
patent: 4320057 (1982-03-01), Freed et al.
patent: 4391752 (1983-07-01), Crossley
patent: 4399136 (1983-08-01), Hassall et al.
patent: 4415496 (1983-11-01), Harris et al.
patent: 4487929 (1984-12-01), Hassall et al.
patent: 4512924 (1985-04-01), Attwood et al.
patent: 4584294 (1986-04-01), Ruyle
patent: 4658024 (1987-04-01), Attwood et al.
patent: 4692438 (1987-09-01), Hassall et al.
patent: 4716232 (1987-12-01), Ternansky
patent: 4734504 (1988-03-01), Holmes
patent: 4734505 (1988-03-01), Holmes
patent: 4762924 (1988-08-01), Hassall et al.
patent: 4772701 (1988-09-01), Attwood et al.
patent: 4782149 (1988-11-01), Lawton et al.
patent: 4785093 (1988-11-01), Hassall et al.
patent: 4808713 (1989-02-01), Attwood et al.
patent: 4824832 (1989-04-01), Flynn et al.
patent: 4826980 (1989-05-01), Hassall et al.
patent: 4879309 (1989-11-01), Doll et al.
patent: 4973585 (1990-11-01), Flynn et al.
patent: 5208230 (1993-05-01), Flynn et al.
patent: 5238932 (1993-08-01), Flynn et al.
patent: 5252601 (1993-10-01), Flynn et al.
patent: 5308841 (1994-05-01), Flynn et al.
patent: 5366973 (1994-11-01), Flynn et al.
patent: 5389628 (1995-02-01), Flynn et al.
patent: 5420271 (1995-05-01), Warshawsky et al.
patent: 5424425 (1995-06-01), Flynn et al.
patent: 5428158 (1995-06-01), Warshawsky et al.
patent: 5430145 (1995-07-01), Flynn et al.
patent: 5455242 (1995-10-01), Warshawsky et al.
patent: 5457196 (1995-10-01), Warshawsky et al.
patent: 5552397 (1996-09-01), Karanewsky et al.
patent: 5731306 (1998-03-01), Flynn et al.
Flynn, et al., J. Am. Chem. Soc. 109, 7914 (1987).
Flynn, et al., Peptide Chemistry (1987); T. Shiba & Sakakibara (ed.), Protein Research Foundation, Osaka (1988).
Flynn, et al., Tetrahedron Letters, vol. 31 (6), 815-88 (1990).
Attwood, et al., J. Chem. Soc. Perkin Trans. I, pp. 1011-1019 (1986).
Natoff, et al., Drugs of the Future, vol. 12 (5): 475-483 (1987).
J. Med. Chem. 1992, 35, 823-832, Timothy D. Ocain et al.
Bioorganic and Medical Chem. Letters, vol. 1, 309, 1991.
W.H. Parsons et al. Biochemical and Biophysical Research Communications vol. 117, No. 1, 1993 (Nov. 30, 1983).
Fournie-Zaluski, Marie-Claude et al., J. Med. Chem., 1992 vol. 35, pp. 2473-2481.
Fournie-Zaluski, Marie-Claude et al., J. Med. Chem., 1992 vol. 35, pp. 1259-1266.
French, John F., Jour. of Pharm and Exper. Therapeutics, vol. 268, No. 1, pp. 180-186, 1986.
Powell Jerry S. et al., Journal of American College of Cardiology, vol. 17, No. 6, pp. 137B-142B (May 1991).
Davis, Harry R. et al., Supplement I Circulation, vol. 86, No. 4 p. I-220 (0873), (Oct. 1992).
Burkholder, et al. Bioorganic and Medical Chem. Letters, vol. 3, No. 2, pp. 231-234, 1993.
Flynn et al., J. Med. Chem. 1993, 36 2420-2423.
34th Nat'l Organic Symposium, Williamsburg, VA, Jun. 11-15, 1995 (poster #133).
ACS Meeting -Aneheim, CA Apr. 2-7, 1995 (poster #161).
ACS Meeting in Chicago, IL Aug. 24, 1995 (poster no. 64).
Beight Douglas W.
Flynn Gary A.
French John F.
Kehne John H.
Mehdi Shujaath
Kurys, Esq. Barbara
Merrell Pharmaceuticals Inc.
Wu Shean C.
LandOfFree
Mercaptoacetylamino 1,3,4,5-tetrahydro-benzo(C)azepin-2-one disu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mercaptoacetylamino 1,3,4,5-tetrahydro-benzo(C)azepin-2-one disu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mercaptoacetylamino 1,3,4,5-tetrahydro-benzo(C)azepin-2-one disu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1321338